Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2005
08/03/2005EP1559432A1 Hm1.24-utilizing cancer vaccines
08/03/2005EP1559429A2 Anti-aging agent
08/03/2005EP1559422A1 Receptor function controlling agent
08/03/2005EP1558650A2 Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders
08/03/2005EP1558647A2 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
08/03/2005EP1558646A2 Single domain antibodies directed against interferon- gamma and uses thereof
08/03/2005EP1558645A2 Stabilized single domain antibodies
08/03/2005EP1558630A2 Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use
08/03/2005EP1558620A1 Ruthenium anticancer complexes
08/03/2005EP1558618A1 5-(1 ,1 -CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO- 5H /-CHROMENO[3,4-f ] QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
08/03/2005EP1558616A2 Meso-substituted porphyrins
08/03/2005EP1558589A2 Compounds, compositions, and methods
08/03/2005EP1558588A2 Compounds, compositions, and methods
08/03/2005EP1558586A2 Inhibitors of akt activity
08/03/2005EP1558568A1 Nitroaniline-based alkylating agents and their use as prodrugs
08/03/2005EP1558566A1 Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same
08/03/2005EP1558289A1 Pharmaceutical composition comprising a cdk inhibitor and gemcitabine
08/03/2005EP1558284A1 Combination therapy with class iii anti-cea monoclonal antibodies and therapeutic agents
08/03/2005EP1558242A1 Combination comprising docetaxel and a cdk inhibitor
08/03/2005EP1558239A1 Combination comprising a cdk inhibitor and cisplatin
08/03/2005EP1558229A1 Combination of a cdk inhibitor and mitoxantrone
08/03/2005EP1399446B1 2,6,9-substituted purine derivatives and their use in the treatment of proliferative disorders
08/03/2005EP1287017B1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
08/03/2005EP1280527B1 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione
08/03/2005EP1237900A4 Subunit optimized fusion proteins
08/03/2005EP1237567B1 Method for administering a cytokine to the central nervous system and the lymphatic system
08/03/2005EP1225896B1 Isoxazole derivatives to be used as phosphodiesterase vii inhibitors
08/03/2005EP1140173B1 Vascular endothelial cell growth factor antagonists and uses thereof
08/03/2005EP1131344B1 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
08/03/2005EP0914435B1 Hybrid interferon compositions and methods of use
08/03/2005EP0851925B1 Human growth hormone variants
08/03/2005CN1650169A Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
08/03/2005CN1650033A Genomic screen for epigenetically silenced genes associated with cancer
08/03/2005CN1650020A Means and methods for the production of adenovirus vectors
08/03/2005CN1650015A DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
08/03/2005CN1650014A Microorganisms as carriers of nucleotide sequences coding for cell antigens used for the treatment of tumors
08/03/2005CN1650011A Methods and compositions for treating neoplasms by ERBB3
08/03/2005CN1650010A Method for inhibiting the expression of a target gene and medicine for treating tumor disease
08/03/2005CN1649902A Internalizing anti-CD74 antibodies and methods of use
08/03/2005CN1649900A Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof
08/03/2005CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
08/03/2005CN1649879A Non-steroidal progesterone receptor modulators
08/03/2005CN1649873A Camptothecin-taxoid conjugates as antimitotic and antitumor agents
08/03/2005CN1649871A Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6, 7, 8, 9-tetrahydropydimido[1, 2-a]pyrimidin-4-one derivatives
08/03/2005CN1649869A Azaindoles as inhibitors of c-Jun N-terminal kinases
08/03/2005CN1649867A Novel 1, 2, 3-substituted indolizine derivatives, inhibitors of FGFs, method for making same and pharmaceutical compositions containing same
08/03/2005CN1649863A Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
08/03/2005CN1649857A Hydroxamic acid derivatives
08/03/2005CN1649853A Thiazolidinones compound, its preparing method and use as medicine
08/03/2005CN1649843A Novel chalcone derivatives and uses thereof
08/03/2005CN1649841A Piperidine derivative compound and drug containing the same compound as active ingredient
08/03/2005CN1649820A Compounds that modulate PPAR activity and methods for their preparation
08/03/2005CN1649645A Depsipeptide for therapy of kidney cancer
08/03/2005CN1649628A Method of encapsulating metal complex within liposomes
08/03/2005CN1649627A Methods and conpositions for treating, preventing or delaying onset of a neoplasm
08/03/2005CN1649624A Use of TNF alpha antibodies and another drug
08/03/2005CN1649622A DNA vaccine against proliferating endothelial cells and methods of use thereof
08/03/2005CN1649621A Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
08/03/2005CN1649618A Methods
08/03/2005CN1649612A Induction method for cell differentiation
08/03/2005CN1649611A Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
08/03/2005CN1649610A Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and DNA repair proc
08/03/2005CN1649595A Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
08/03/2005CN1649593A Use of 2-alkoxyphenyl-substituted imidazotriazinones
08/03/2005CN1649587A Use of epothilones in the treatment of brain diseases associated with proliferative processes
08/03/2005CN1649586A Heterocyclic amide derivatives for the treatment of diabetes and other diseases
08/03/2005CN1649585A Epothilone derivative for the treatment of hepatoma and other cancer diseases
08/03/2005CN1649583A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
08/03/2005CN1649582A Amino-methyl substituted tetracycline compounds
08/03/2005CN1649581A Substituted 3-amino-thieno(2, 3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
08/03/2005CN1649576A Methods and compositions for treatment of cancer pain
08/03/2005CN1649574A Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
08/03/2005CN1649551A Drug-delivery endovascular stent and method for treating restenosis
08/03/2005CN1649513A Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
08/03/2005CN1648258A Compound 4-methoxy-7-methyl-3-oxo-1, 3-dihydro isophenol furan-5-formaldehyde and its preparing method
08/03/2005CN1648247A Method for producing recombined blood vessel chalone in bacillus coli and its use
08/03/2005CN1648132A Taxinol water soluble derivative
08/03/2005CN1648126A Compound and its preparing method and use
08/03/2005CN1647825A Anti-nasopharyngeal carcinoma target coupling preparation and its preparing method
08/03/2005CN1647821A Method for preparing specific nano vaccine for stomach cancer
08/03/2005CN1647820A Use of protein kinase Czeta in regulating tumor cell chemotactic movement
08/03/2005CN1647801A Staphylococcus aureus metabolic product medicine oral preparation and its use
08/03/2005CN1647799A Toad extract liposome preparation for injection and its preparing method
08/03/2005CN1647797A Formula of submicro emulsion of norcantharidine injection and preparing process
08/03/2005CN1213070C Monoclonal antibodies directed against the G3BP protein and use
08/03/2005CN1213058C FAP-activated anti-tumor compounds
08/03/2005CN1213046C Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors
08/03/2005CN1213045C Tyrosine kinase inhibitors
08/03/2005CN1213042C Novel taxoids, preparation thereof and pharmaceutical compositions containing same
08/03/2005CN1213040C Serine protese inhibitors
08/03/2005CN1213022C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
08/03/2005CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors
08/03/2005CN1213017C Propynyl or diene diaryl compounds
08/03/2005CN1212862C Use of intravenous contrast agents for projection mammography
08/02/2005US6924376 Compounds, compositions and methods
08/02/2005US6924360 Antitumor agents
08/02/2005US6924357 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy
08/02/2005US6924309 Modulation cystic fibrosis; antiinflammatory agents; antiallergens; rheumatic diseases; autoimmune diseases
08/02/2005US6924305 Diazocine derivatives and their use as tryptase inhibitors
08/02/2005US6924297 Naphathalene derivatives which bind to the EP4 receptor
1 ... 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 ... 2211